Metraipolis › archive › dc_f92ee1e6be89
Government innovation subsidy, executives' academic capital and innovation quality: Evidence from pharmaceutical companies in China — Europe PMC PMID:36710848
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/36710848
- DOI
- 10.3389/fpsyg.2022.1092162
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T01:33:24.198Z
- SHA-256 of the archived text
afd6eaff7706c34f6ca9e994d04034f7fdcc8487965bdc9f7dc42fab346acc49- Stable URL of this page
https://metraipolis.com/documento/dc_f92ee1e6be89
How to cite
Government innovation subsidy, executives' academic capital and innovation quality: Evidence from pharmaceutical companies in China — Europe PMC PMID:36710848 — Europe PMC (en), https://europepmc.org/article/MED/36710848 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f92ee1e6be89 (Metraipolis archive dc_f92ee1e6be89, sha256 afd6eaff7706c34f6ca9e994d04034f7fdcc8487965bdc9f7dc42fab346acc49)
BibTeX
@misc{dcf92ee1e6be89,
title = {Government innovation subsidy, executives' academic capital and innovation quality: Evidence from pharmaceutical companies in China — Europe PMC PMID:36710848},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/36710848},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f92ee1e6be89; sha256 afd6eaff7706c34f6ca9e994d04034f7fdcc8487965bdc9f7dc42fab346acc49},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/36710848. Agents can read the archived copy with the MCP tool read_document.